Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Virology|January 13, 2012
Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinomaAndrea M Murphy, Dahlia M Besmer, Megan Moerdyk-Schauwecker, et al.Virology|February 23, 2010
Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responsesVinita S Chauhan, Samantha R Furr, David G Sterka, et al.Molecular Therapy. Oncology|December 11, 2025
Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virusCassandra Catacalos-Goad, Dakota W Goad, Molly C Holbrook, et al.Journal of Virology|July 19, 2013
Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinomaEric Hastie, Dahlia M Besmer, Nirav R Shah, et al.Journal of Surgical Oncology|January 22, 2013
The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancerJennifer M Curry, Kyle J Thompson, Shanti G Rao, et al.Journal for Immunotherapy of Cancer|May 12, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.Biorxiv : the Preprint Server for Biology|September 26, 2025
Pancreatic tumor microenvironment reprogramming via alloantigenexpressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.Pageof 4